MMP26 and prostate adenocarcinoma: Analysis of the PRAD TCGA [50] cohort (n = 407) revealed that MMP11 and MMP26 expression levels have an opposite and significant association with BRFS, and MMP11 high / MMP26 low gene expression signature even further improves the outcome prediction (Fig. 5CDE).